The PI3K/Akt and ERK1/2 signaling pathways mediate the erythropoietin- modulated calcium influx in kainic acid-induced epilepsy

NeuroReport

Volumn 24, Issue 6, 2013, Pages 335-341

  Zheng, Honghua ^a   Wang, Xiaojing ^d   Tang, Zhengang ^c   Zheng, Weihong ^b   Li, Zhengli ^c  

^a Xiamen Medical College   (China)

^b ZHONGSHAN HOSPITAL OF XIAMEN UNIVERSITY   (China)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^d BENGBU MEDICAL COLLEGE   (China)

Author keywords

calcium influx; erythropoietin; kainic acid; PI3K Akt and ERK1 2

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 MORPHOLINO 8 PHENYLCHROMONE; ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; KAINIC ACID; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RECOMBINANT ERYTHROPOIETIN; SMALL INTERFERING RNA; VOLTAGE GATED CALCIUM CHANNEL;

ACTION POTENTIAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM CURRENT; CALCIUM TRANSPORT; CONTROLLED STUDY; EPILEPSY; GENETIC TRANSFECTION; HIPPOCAMPUS; MALE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SPIKE WAVE;

ANIMALS; BLOTTING, WESTERN; CA3 REGION, HIPPOCAMPAL; CALCIUM; CELLS, CULTURED; ELECTROPHYSIOLOGICAL PHENOMENA; EPILEPSY; ERYTHROPOIETIN; EVOKED POTENTIALS; EXCITATORY AMINO ACID AGONISTS; HIPPOCAMPUS; KAINIC ACID; MALE; MAP KINASE SIGNALING SYSTEM; NEURONS; ONCOGENE PROTEIN V-AKT; PATCH-CLAMP TECHNIQUES; PHOSPHATIDYLINOSITOL 3-KINASES; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 84875873031     PISSN: 09594965     EISSN: 1473558X     Source Type: Journal    
DOI: 10.1097/WNR.0b013e32835ffe03     Document Type: Article

References (20)

1. Morishita E, Masuda S, Nagao M, Yasuda Y, Sasaki R. Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death. Neuroscience 1997; 76:105-116. (Pubitemid 26407940)
2. Lombardero M, Kovacs K, Scheithauer BW. Erythropoietin: a hormone with multiple functions. Pathobiology 2011; 78:41-53.
3. Jun Y, JiangTao X, YuanGui H, YongBin S, Jun Z, XiaoJun M. Erythropoietin pre-treatment prevents cognitive impairments following status epilepticus in rats. Brain Res 2009; 1282:57-66.
4. Kondo A, Shingo T, Yasuhara T, Kuramoto S, Kameda M, Kikuchi Y. Erythropoietin exerts anti-epileptic effects with the suppression of aberrant new cell formation in the dentate gyrus and upregulation of neuropeptide Y in seizure model of rats. Brain Res 2009; 1296:127-136.
5. Raza M, Blair RE, Sombati S, Carter DS, Deshpande LS, DeLorenzo RJ. Evidence that injury-induced changes in hippocampal neuronal calcium dynamics during epileptogenesis cause acquired epilepsy. Proc Natl Acad Sci USA. 2004; 101:17522-17527. (Pubitemid 39657436)
6. Genc S, Koroglu TF, Genc K. Erythropoietin as a novel neuroprotectant. Restor Neurol Neurosci 2004; 22:105-119. (Pubitemid 38850338)
7. Zhu W, Zheng H, Shao X,Wang W, Yao Q, Li Z. Excitotoxicity of TNFalpha derived from KA activated microglia on hippocampal neurons in vitro and in vivo. J Neurochem 2010; 114:386-396.
8. Zheng H, Zhu W, Zhao H,Wang X,Wang W, Li Z. Kainic acid-activated microglia mediate increased excitability of rat hippocampal neurons in vitro and in vivo: crucial role of interleukin-1beta. Neuroimmunomodulation 2010; 17:31-38.
9. Berzhanskaya J, Urban NN, Barrionuevo G. Electrophysiological and pharmacological characterization of the direct perforant path input to hippocampal area CA3. J Neurophysiol 1998; 79:2111-2118. (Pubitemid 28183342)
10. Cooke SF, Bliss TV. Plasticity in the human central nervous system. Brain 2006; 129:1659-1673. (Pubitemid 43999401)
11. Quelle FW,Wang D, Nosaka T, Thierfelder WE, Stravopodis D,Weinstein Y. Erythropoietin induces activation of Stat5 through association with specific tyrosines on the receptor that are not required for a mitogenic response. Mol Cell Biol 1996; 16:1622-1631. (Pubitemid 26095634)
12. Zhao W, Kitidis C, Fleming MD, Lodish HF, Ghaffari S. Erythropoietin stimulates phosphorylation and activation of GATA-1 via the PI3-kinase/AKT signaling pathway. Blood 2006; 107:907-915. (Pubitemid 43158401)
13. Brines ML, Ghezzi P, Keenan S, Agnello D, de Lanerolle NC, Cerami C. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc Natl Acad Sci USA 2000; 97:10526-10531.
14. Mennini T, De Paola M, Bigini P, Mastrotto C, Fumagalli E, Barbera S. Nonhematopoietic erythropoietin derivatives prevent motoneuron degeneration in vitro and in vivo. Mol Med 2006; 12:153-160. (Pubitemid 44646344)
15. Delorenzo RJ, Sun DA, Deshpande LS. Cellular mechanisms underlying acquired epilepsy: the calcium hypothesis of the induction and maintenance of epilepsy. Pharmacol Ther 2005; 105:229-266. (Pubitemid 40297893)
16. Andoh T, Echigo N, Kamiya Y, Hayashi M, Kudoh I, Goto T. Effects of erythropoietin on intracellular calcium concentration of rat primary cortical neurons. Brain Res 2011; 1387:8-18.
17. Chu K, Jung KH, Lee ST, Kim JH, Kang KM, Kim HK. Erythropoietin reduces epileptogenic processes following status epilepticus. Epilepsia 2008; 49:1723-1732.
18. Won YJ, Yoo JY, Lee JH, Hwang SJ, Kim D, Hong HN. Erythropoietin is neuroprotective on GABAergic neurons against kainic acid-excitotoxicity in the rat spinal cell cultures. Brain Res 2007; 1154:31-39. (Pubitemid 46856347)
19. Dolphin AC. A short history of voltage-gated calcium channels. Br J Pharmacol 2006; 147:S56-S62. (Pubitemid 43077262)
20. Livnah O, Stura EA, Middleton SA, Johnson DL, Jolliffe LK, Wilson IA. Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation. Science 1999; 283:987-990.